Niagen Bioscience, Inc.
NAGE· Nasdaq
NAGENiagen Bioscience, Inc.
Filed Mar 17, 2016 · 10-K · 75 days after period end · 0001415889-16-005140
| Metric | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012dderived from reported figures |
|---|---|---|---|---|
| Revenue | $4.36M | $4.24M | $2.40M | $3.52M |
| Net Income | -$1.43M | -$1.23M | -$724.32K | -$1.70M |
| EPS Diluted | -$0.04 | -$0.03 | -$0.01 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Niagen Bioscience, Inc. · CIK 1386570 · Engraved from SEC EDGAR
ended Jan 2, 2016 · filed Mar 17, 2016 · 75 d after period end
